NASONEX (REMEDYREPACK INC.)


Welcome to the PulseAid listing for the NASONEX drug offered from REMEDYREPACK INC.. This Corticosteroid [EPC],Corticosteroid Hormone Receptor Agonists [MoA],Corticosteroid Hormone Receptor Agonists [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: REMEDYREPACK INC.
NON-PROPRIETARY NAME: Mometasone furoate monohydrate
SUBSTANCE NAME: MOMETASONE FUROATE MONOHYDRATE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Corticosteroid [EPC],Corticosteroid Hormone Receptor Agonists [MoA],Corticosteroid Hormone Receptor Agonists [MoA]
ROUTE: NASAL
DOSAGE FORM: SPRAY, METERED
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 2014-09-23
END MARKETING DATE: 0000-00-00


NASONEX HUMAN PRESCRIPTION DRUG Details:

Item DescriptionNASONEX from REMEDYREPACK INC.
LABELER NAME: REMEDYREPACK INC.
DEA SCHEDULE:
ACTIVE STRENGTH: 50(ug/1)
START MARKETING DATE: 2014-09-23
END MARKETING DATE: 0000-00-00
PRODUCT ID: 52125-459_3776bfe7-2e95-0aca-e054-00144ff88e88
PRODUCT NDC: 52125-459
APPLICATION NUMBER: NDA020762

Other MOMETASONE FUROATE MONOHYDRATE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Merck Sharp & Dohme Corp.NASONEX
REMEDYREPACK INC.NASONEX
Sandoz Inc.Mometasone Furoate Monohydrate